Corilagin is a potent inhibitor of NF-kappaB activity and downregulates TNF-alpha induced expression of IL-8 gene in cystic fibrosis IB3-1 cells

International Immunopharmacology

Volumn 13, Issue 3, 2012, Pages 308-315

  Gambari, Roberto ^a   Borgatti, Monica ^a   Lampronti, Ilaria ^a   Fabbri, Enrica ^a   Brognara, Eleonora ^a   Bianchi, Nicoletta ^a   Piccagli, Laura ^a   Yuen, Marcus Chun Wah ^b   Kan, Chi Wai ^b   Hau, Desmond Kwok Po ^c   Fong, Wang Fun ^c   Wong, Wai Yeung ^c   Wong, Raymond Siu Ming ^d   Chui, Chung Hin ^b,d  

^a UNIVERSITY OF FERRARA   (Italy)

^b HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

^c HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

^d CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Corilagin; Cystic fibrosis; IB3 1; IL 8; NF kappaB; TNF alpha

Indexed keywords

CORILAGIN; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ARTICLE; BRONCHUS DISEASE; CELL GROWTH; CELL PROLIFERATION; CELL STIMULATION; CELL VIABILITY; CONTROLLED STUDY; CYSTIC FIBROSIS; CYTOKINE PRODUCTION; CYTOTOXICITY; DNA BINDING; DRUG DNA INTERACTION; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN SECRETION;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BASE SEQUENCE; CELL LINE; CHEMOKINE CCL2; CHEMOKINE CCL5; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DOWN-REGULATION; GLUCOSIDES; HUMANS; INTERLEUKIN-8; MUTATION; NF-KAPPA B; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84861452853     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2012.04.010     Document Type: Article

References (58)

1. Kinoshita S, Inoue Y, Nakama S, Ichiba T, Aniya Y. Antioxidant and hepatoprotective actions of medicinal herb, Terminalia catappa L. from Okinawa Island and its tannin corilagin. Phytomedicine 2007;14:755-62. (Pubitemid 47539096)
2. Gambari R. Predictive analyses of biological effects of natural products: from plant extracts to biomolecular laboratory and computer modeling. Evid Based Complement Alternat Med 2009 [Sep 14, 2009].
3. Hau DKP, Gambari R, Wong RSM, Yuen MCW, Cheng GYM, Tong CSW, et al. Phyllanthus urinaria extract attenuates acetaminophen induced hepatotoxicity: involvement of cytochrome P450 CYP2E1. Phytomedicine 2009;16:751-60.
4. Lai CH, Fang SH, Rao YK, Geethangili M, Tang CH, Lin YJ, et al. Inhibition of Helicobacter pylori-induced inflammation in human gastric epithelial AGS cells by Phyllanthus urinaria extracts. J Ethnopharmacol 2008;118(3):522-6.
5. Jikai L, Yue H, Henkel T, Weber K. One step purification of corilagin and ellagic acid from Phyllanthus urinaria using high-speed countercurrent chromatography. Phytochem Anal 2002;13(1):1-3. (Pubitemid 34126607)
6. Bezzerri V, Borgatti M, Nicolis E, Lampronti I, Dechecchi MC, Mancini I, et al. Transcription factor oligodeoxynucleotides to NF-kappaB inhibit transcription of IL-8 in bronchial cells. Am J Respir Cell Mol Biol 2008;39:86-96. (Pubitemid 351883962)
7. DiMango E, Ratner AJ, Bryan R, Tabibi S, Prince A. Activation of NF-kappaB by adherent Pseudomonas aeruginosa in normal and cystic fibrosis respiratory epithelial cells. J Clin Invest 1998;101:2598-605.
8. Joseph T, Look D, Ferkol T. NF-kappaB activation and sustained IL-8 gene expression in primary cultures of cystic fibrosis airway epithelial cells stimulated with Pseudomonas aeruginosa. Am J Physiol Lung Cell Mol Physiol 2005;288:L471-9. (Pubitemid 40229512)
9. Saadane A, Masters S, DiDonato J, Li J, Berger M. Parthenolide inhibits IkappaB kinase, NF-kappaB activation, and inflammatory response in cystic fibrosis cells and mice. Am J Respir Cell Mol Biol 2007;36:728-36. (Pubitemid 46871428)
10. Sadikot RT, Zeng H, Joo M, Everhart MB, Sherrill TP, Li B, et al. Targeted immunomodulation of the NF-kappaB pathway in airway epithelium impacts host defense against Pseudomonas aeruginosa. J Immunol 2006;176:4923-30.
11. Tchilibon S, Zhang J, Yang Q, Eidelman O, Kim H, Caohuy H, et al. Amphiphilic pyridinium salts block TNF alpha/NF kappa B signaling and constitutive hypersecretion of interleukin-8 (IL-8) from cystic fibrosis lung epithelial cells. Biochem Pharmacol 2005;70:381-93. (Pubitemid 40905110)
12. Boucher RC. New concepts of the pathogenesis of cystic fibrosis lung disease. Eur Respir J 2004;23:146-58. (Pubitemid 38088512)
13. Davies JC, Alton EW, Bush A. Cystic fibrosis. BMJ 2007;335:1255-9.
14. Dorwart M, Thibodeau P, Thomas P. Cystic fibrosis: recent structural insights. J Cyst Fibros 2004;2:91-4. (Pubitemid 40045575)
15. Lewis MJ, Lewis III EH, Amos JA, Tsongalis GJ. Cystic fibrosis. Am J Clin Pathol 2003;120:S3-S13.
16. Bonfield TL, Panuska JR, Konstan MW, Hilliard KA, Hilliard JB, Ghnaim H, et al. Inflammatory cytokines in cystic fibrosis lungs. Am J Respir Crit Care Med 1995;152: 2111-8.
17. Khan TZ, Wagener JS, Bost T, Martinez J, Accurso FJ, Riches DW. Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit Care Med 1995;151: 1075-82.
18. Puchelle E, De Bentzmann S, Hubeau C, Jacquot J, Gaillard D. Mechanisms involved in cystic fibrosis airway inflammation. Pediatr Pulmonol 2001;S23:143-5. (Pubitemid 33021831)
19. Belcher CN, Vij N. Protein processing and inflammatory signaling in cystic fibrosis: challenges and therapeutic strategies. Curr Mol Med 2010;10:82-94.
20. Ross KR, Chmiel JF, Konstan MW. The role of inhaled corticosteroids in the management of cystic fibrosis. Paediatr Drugs 2009;11:101-13.
21. Zemanick ET, Harris JK, Conway S, Konstan MW, Marshall B, Quittner AL, et al. Measuring and improving respiratory outcomes in cystic fibrosis lung disease: opportunities and challenges to therapy. J Cyst Fibros 2010;9:1-16.
22. Hau DK, Zhu GY, Leung AK, Wong RS, Cheng GY, Lai PB, et al. In vivo anti-tumour activity of corilagin on Hep3B hepatocellular carcinoma. Phytomedicine 2010;18(1): 11-5.
23. Zhao L, Zhang SL, Tao JY, Pang R, Jin F, Guo YJ, et al. Preliminary exploration on anti-inflammatory mechanism of corilagin (beta-1-O-galloyl- 3,6-(R)-hexahydroxydiphemoyl-D-glucose) in vitro. Int Immunopharmacol 2008;8: 1059-64.
24. Dong XR, Luo M, Fan L, Zhang T, Liu L, Dong JH, et al. Corilagin inhibits the double strand-triggered NF-kappaB pathway in irradiated microglial cells. Int J Mol Med 2010;25:531-6.
25. Gambari R, Borgatti M, Bezzerri V, Nicolis E, Lampronti I, Dechecchi MC, et al. Decoy oligodeoxyribonucleotides and peptide nucleic acids-DNA chimeras targeting nuclear factor kappa-B: inhibition of IL-8 gene expression in cystic fibrosis cells infected with Pseudomonas aeruginosa. Biochem Pharmacol 2010;80:1887-94.
26. Nicolis E, Lampronti I, Dechecchi MC, Borgatti M, Tamanini A, Bianchi N, et al. Pyrogallol, an active compound from the medicinal plant Emblica officinalis, regulates expression of pro-inflammatory genes in bronchial epithelial cells. Int Immunopharmacol 2008;8:1672-80.
27. Nicolis E, Lampronti I, Dechecchi MC, Borgatti M, Tamanini A, Bezzerri V, et al. Modulation of expression of IL-8 gene in bronchial epithelial cells by 5-methoxypsoralen. Int Immunopharmacol 2009;9:1411-22.
28. Dechecchi MC, Nicolis E, Mazzi P, Cioffi F, Bezzerri V, Lampronti I, et al. Modulators of sphingolipid metabolism reduce lung inflammation. Am J Respir Cell Mol Biol 2011;45(4):825-33.
29. Borgatti M, Mazzitelli S, Breveglieri G, Gambari R, Nastruzzi C. Induction by TNF-αof IL-6 and IL-8 in cystic fibrosis bronchial IB3-1 epithelial cells encapsulated in alginate microbeads. J Biomed Biotechnol 2010:907964.
30. Bezzerri V, Borgatti M, Finotti A, Tamanini A, Gambari R, Cabrini G. Mapping the transcriptional machinery of the IL-8 gene in human bronchial epithelial cells. J Immunol 2011;187:6069-81.
31. Borgatti M, Bezzerri V, Mancini I, Nicolis E, Dechecchi MC, Lampronti I, et al. Induction of IL-6 gene expression in a CF bronchial epithelial cell line by Pseudomonas aeruginosa is dependent on transcription factors belonging to the Sp1 superfamily. Biochem Biophys Res Commun 2007;357:977-83. (Pubitemid 46693668)
32. Romagnoli R, Baraldi PG, PavaniMG, TabriziMA, Preti D, Fruttarolo F, et al. Synthesis and biological evaluation of 2-amino-3-(3′,4′, 5′-trimethoxybenzoyl)-5-aryl thiophenes as a new class of potent antitubulin agents. J Med Chem 2006;49(13): 3906-15. (Pubitemid 43967887)
33. Lampronti I, Martello D, Bianchi N, Borgatti M, Lambertini E, Piva R, et al. In vitro antiproliferative effects on human tumor cell lines of extracts from the Bangladeshi medicinal plant Aegle marmelos Correa. Phytomedicine 2003;10(4):300-8. (Pubitemid 36597166)
34. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55-63. (Pubitemid 14203433)
35. Piccagli L, Fabbri E, Borgatti M, Bezzerri V, Mancini I, Nicolis E, et al. Docking of molecules identified in bioactive medicinal plants extracts into the p50 NF-kappaB transcription factor: correlation with inhibition of NF-kappaB/DNA interactions and inhibitory effects on IL-8 gene expression. BMC Struct Biol 2008;8:38.
36. Piccagli L, Fabbri E, Borgatti M, Bianchi N, Bezzerri V, Mancini I, et al. Virtual screening against p50 NF-kappaB transcription factor for the identification of inhibitors of the NF-kappaB-DNA interaction and expression of NF-kappaB upregulated genes. ChemMedChem 2009;4:2024-33.
37. Maestro (v7.0.113) - a unified interface for all Schrodinger products, developed and marketed by Schrodinger, LLC. NY, copy-right. http://www. schrodinger.com 2005.
38. Jorgensen WL, Maxwell DS, Tirado-Rives J. Development and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids. J Am Chem Soc 1996;118:11225-36. (Pubitemid 26399746)
39. Halgren TA, Murphy RB, Friesner RA, Beard HS, Frye LL, Pollard WT, et al. Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. J Med Chem 2004;47:1750-9. (Pubitemid 38380918)
40. Borgatti M, Breda L, Cortesi R, Nastruzzi C, Romanelli A, Saviano M, et al. Cationic liposomes as delivery systems for double-stranded PNA-DNA chimeras exhibiting decoy activity against NF-kappaB transcription factors. Biochem Pharmacol 2002;64:609-16.
41. Borgatti M, Lampronti I, Romanelli A, Pedone C, Saviano M, Bianchi N, et al. Transcription factor decoy molecules based on a peptide nucleic acid (PNA)-DNA chimera mimicking Sp1 binding sites. J Biol Chem 2003;278:7500-9. (Pubitemid 36800757)
42. Borgatti M, Rizzo R, Canto MB, Fumagalli D, Renzini MM, Fadini R, et al. Release of sICAM-1 in oocytes and in vitro fertilized human embryos. PLoS One 2008;3:e3970.
43. Penolazzi L, Lambertini E, Tavanti E, Torreggiani E, Vesce F, Gambari R, et al. Evaluation of chemokine and cytokine profiles in osteoblast progenitors from umbilical cord blood stem cells by BIO-PLEX technology. Cell Biol Int 2008;32:320-5. (Pubitemid 351282502)
44. Sharma RK, Chopra S, Sharma SD, Pande V, Ramos MJ, Meguro K, et al. Biological evaluation, chelation, and molecular modeling studies of novel metal-chelating inhibitors of NF-kappaB-DNA binding: structure activity relationships. J Med Chem 2006;49:3595-601. (Pubitemid 43902464)
45. Juang LJ, Sheu SJ. Chemical identification of the sources of commercial Fructus Chebulae. Phytochem Anal 2005;16(4):246-51.
46. Juang LJ, Sheu SJ, Lin TC. Determination of hydrolyzable tannins in the fruit of Terminalia chebula Retz. by high-performance liquid chromatography and capillary electrophoresis. J Sep Sci 2004;27(9):718-24.
47. Kala CP. Aboriginal uses and management of ethnobotanical species in deciduous forests of Chhattisgarh state in India. J Ethnobiol Ethnomed 2009;5:20.
48. Okabe S, Suganuma M, Imayoshi Y, Taniguchi S, Yoshida T, Fujiki H. New TNF-alpha releasing inhibitors, geraniin and corilagin, in leaves of Acer nikoense, Megusurino-ki. Biol Pharm Bull 2001;24(10):1145-8. (Pubitemid 33049076)
49. Devkota HP, Basnet P, Yahara S. Diterpene esters and phenolic compounds from Sapium insigne (ROYLE) BENTH. ex HOOK. fil. Chem Pharm Bull(Tokyo) 2009;57(11):1289-91.
50. Colombo R, de L Batista AN, Teles HL, Silva GH, BomfimGC, Burgos RC, et al. Validated HPLC method for the standardization of Phyllanthus niruri (herb and commercial extracts) using corilagin as a phytochemical marker. Biomed Chromatogr 2009;23(6): 573-80.
51. Fang SH, Rao YK, Tzeng YM. Anti-oxidant and inflammatory mediator's growth inhibitory effects of compounds isolated fromPhyllanthus urinaria. J Ethnopharmacol 2008;116(2):333-40.
52. Boyce BF, Yao Z, Xing L. Functions of nuclear factor kappaB in bone. Ann NY Acad Sci 2010;1192:367-75.
53. Piva R, Penolazzi L, Borgatti M, Lampronti I, Lambertini E, Torreggiani E, et al. Apoptosis of human primary osteoclasts treated with molecules targeting nuclear factor-kappaB. Ann NY Acad Sci 2009;1171:448-56.
54. Atkinson GP, Nozell SE, Benveniste ET. NF-kappaB and STAT3 signaling in glioma: targets for future therapies. Expert Rev Neurother 2010;10:575-86.
55. Wong KK, Jacks T, Dranoff G. NF-kappaB fans the flames of lung carcinogenesis. Cancer Prev Res (Phila Pa) 2010;3:403-5.
56. Cabrini G, Bezzerri V, Mancini I, Nicolis E, Dechecchi MC, Tamanini A, et al. Targeting transcription factor activity as a strategy to inhibit pro-inflammatory genes involved in cystic fibrosis: decoy oligonucleotides and low-molecular weight compounds. Curr Med Chem 2010;17(35):4392-404.
57. Cigana C, Nicolis E, Pasetto M, Assael BM, Melotti P. Anti-inflammatory effects of azithromycin in cystic fibrosis airway epithelial cells. Biochem Biophys Res Commun 2006;350:977-82. (Pubitemid 44584188)
58. Borgatti M, Chilin A, Piccagli L, Lampronti I, Bianchi N, Mancini I, et al. Development of a novel furocoumarin derivative inhibiting NF-κB dependent biological functions: design, synthesis and biological effects. Eur J Med Chem 2011;46(10): 4870-7.